Xiaoxuan Tu

811 total citations · 1 hit paper
12 papers, 593 citations indexed

About

Xiaoxuan Tu is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Xiaoxuan Tu has authored 12 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Xiaoxuan Tu's work include Cancer Immunotherapy and Biomarkers (5 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). Xiaoxuan Tu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). Xiaoxuan Tu collaborates with scholars based in China, Australia and Canada. Xiaoxuan Tu's co-authors include Weijia Fang, Weiqin Jiang, Yi Zheng, Peng Zhao, Hangyu Zhang, Shunfeng Cai, Tingting Wang, Ruixue Song, Peilu Li and Yun Huang and has published in prestigious journals such as Nano Letters, British Journal of Cancer and Molecular Therapy.

In The Last Decade

Xiaoxuan Tu

12 papers receiving 587 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma

2019 392 citations Yi Zheng, Tingting Wang et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoxuan Tu China	9	362	292	101	98	92	12	593
Katrina Nicholes United States	7	145 0.4×	326 1.1×	53 0.5×	163 1.7×	67 0.7×	7	651
Yinan Shen China	16	386 1.1×	224 0.8×	111 1.1×	118 1.2×	202 2.2×	37	855
Yanan Gao China	9	165 0.5×	199 0.7×	82 0.8×	195 2.0×	80 0.9×	11	505
Nikola Baschuk Australia	14	212 0.6×	256 0.9×	50 0.5×	324 3.3×	107 1.2×	21	739
Takeshi Isoyama Japan	11	166 0.5×	334 1.1×	135 1.3×	39 0.4×	44 0.5×	30	620
Isao Miyazaki Japan	12	251 0.7×	215 0.7×	48 0.5×	99 1.0×	19 0.2×	35	651
January T. Salas United States	9	310 0.9×	131 0.4×	44 0.4×	213 2.2×	156 1.7×	9	558
Chunxiao Liu China	10	177 0.5×	210 0.7×	67 0.7×	141 1.4×	52 0.6×	16	499
Fubiao Kang China	15	323 0.9×	234 0.8×	59 0.6×	370 3.8×	73 0.8×	26	782
Fangyin Zeng China	11	133 0.4×	295 1.0×	151 1.5×	92 0.9×	41 0.4×	25	544

Countries citing papers authored by Xiaoxuan Tu

Since Specialization

Citations

This map shows the geographic impact of Xiaoxuan Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxuan Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxuan Tu more than expected).

Fields of papers citing papers by Xiaoxuan Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxuan Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxuan Tu. The network helps show where Xiaoxuan Tu may publish in the future.

Co-authorship network of co-authors of Xiaoxuan Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxuan Tu. A scholar is included among the top collaborators of Xiaoxuan Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxuan Tu. Xiaoxuan Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Tu, Xiaoxuan, et al.. (2025). Serum Olink Targeted Proteomics Identifies IL-17A as a Prospective Inflammatory Marker for the Prediction and Diagnosis of Kawasaki Disease. Journal of Inflammation Research. Volume 18. 3093–3103. 1 indexed citations

2.

Li, Bin, Xudong Zhu, Jing Ge, et al.. (2025). Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8+ T cell activation in patients with advanced colorectal cancer. Molecular Therapy. 33(9). 4509–4528. 3 indexed citations

3.

Zhang, Hangyu, Xiaoxuan Tu, Zhou Tong, et al.. (2024). The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient. Cancer Gene Therapy. 31(9). 1412–1426. 10 indexed citations

4.

Tu, Xiaoxuan, Yi Zheng, Chenglin Mu, et al.. (2024). S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function. Journal of Experimental & Clinical Cancer Research. 43(1). 72–72. 8 indexed citations

5.

Shi, Jiawei, Junwei Liu, Xiaoxuan Tu, et al.. (2022). Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy. Journal for ImmunoTherapy of Cancer. 10(1). e003133–e003133. 58 indexed citations

6.

Liu, Jiao, Xiaoxuan Tu, Lulu Liu, & Weijia Fang. (2022). Advances in CAR-T cell therapy for malignant solid tumors. Journal of Zhejiang University (Medical Sciences). 51(2). 175–184. 2 indexed citations

7.

Zhang, Xujun, Kefan Bi, Xiaoxuan Tu, et al.. (2021). Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer. Cancer Medicine. 10(23). 8338–8351. 10 indexed citations

8.

Tu, Xiaoxuan, Xiangying Zhang, Shuwen Han, et al.. (2020). Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy. Supportive Care in Cancer. 28(11). 5569–5579. 20 indexed citations

9.

Hu, Wei, Jie Gao, Bing‐Feng Ju, et al.. (2020). Ultra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells. Nano Letters. 20(7). 5133–5140. 23 indexed citations

10.

Zheng, Yi, Tingting Wang, Xiaoxuan Tu, et al.. (2019). Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 193–193. 392 indexed citations breakdown →

11.

Cong, Yan, Xiaoxuan Tu, Wei Wu, et al.. (2019). Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?. World Journal of Clinical Cases. 7(11). 1253–1261. 13 indexed citations

12.

Zheng, Yi, Xiaoxuan Tu, Peng Zhao, et al.. (2018). A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin. British Journal of Cancer. 119(3). 291–295. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact